Plasmatic Soluble Receptor for Advanced Glycation End Products as a New Oxidative Stress Biomarker in Patients with Prosthetic-Joint-Associated Infections?
Autor: | Alessandra Barassi, M. Marazzi, Barbara Bonomelli, Massimiliano Marco Corsi Romanelli, Lorenzo Drago, Giancarlo Goi, Emanuela Galliera, Nadia Papini, Daniela Erba, Luca Massaccesi |
---|---|
Rok vydání: | 2017 |
Předmět: |
0301 basic medicine
Adult Male Antioxidant Prosthesis-Related Infections Article Subject Thiobarbituric acid medicine.medical_treatment Joint Prosthesis Clinical Biochemistry Receptor for Advanced Glycation End Products Pharmacology medicine.disease_cause Thiobarbituric Acid Reactive Substances Proinflammatory cytokine 03 medical and health sciences chemistry.chemical_compound Glycation Genetics TBARS Medicine Humans Molecular Biology Aged chemistry.chemical_classification Reactive oxygen species lcsh:R5-920 business.industry Biochemistry (medical) General Medicine Middle Aged Oxidative Stress 030104 developmental biology chemistry Biomarker (medicine) Female business lcsh:Medicine (General) Reactive Oxygen Species Oxidative stress Biomarkers Research Article |
Zdroj: | Disease Markers Disease Markers, Vol 2017 (2017) |
ISSN: | 1875-8630 |
Popis: | Prosthetic joint infection (PJI) is the most common cause of failure of total joint arthroplasty, but a gold standard for PJI diagnosis is still lacking. Advanced glycation end products (AGEs) are proinflammatory molecules inducing intracellular oxidative stress (OS) after binding to their cell membrane receptors (RAGE). The aim of this study was to evaluate plasmatic soluble receptor for advanced glycation end products (sRAGE), as a new OS and infection marker correlating sRAGE to the level of OS and antioxidant defenses, in PJI, in order to explore the possible application of this new biomarker in the early diagnosis of PJI. Plasmatic sRAGE levels (by ELISA assay), plasma antioxidant total defenses (by lag time method), plasma reactive oxygen species (ROS), and thiobarbituric acid reactive substance (TBARS) levels (by colorimetric assay) were evaluated in 11 PJI patients and in 30 matched controls. ROS and TBARS were significantly higher (p<0.001) while plasma total antioxidant capacity and sRAGE were significantly lower (p<0.01) in patients with PJI compared to controls. Our results confirm the OS in PJI and show a strong negative correlation between the level of sRAGE and oxidative status, suggesting the plasmatic sRAGE as a potential marker for improving PJI early diagnosis. |
Databáze: | OpenAIRE |
Externí odkaz: |